Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy

Abstract

High plasma CFDNA is associated with aggressive tumor behavior and poor survival outcomes in these patients.